Vincent Lam
Johns Hopkins University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Vincent Lam as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:59 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05950139 · Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLCSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · recruiting · NSCLC Stage IV, ALK Fusion Protein Expression · principal investigator
- Ph1/Ph2NCT03610711 · REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · active not recruiting · Gastroesophageal Cancer, Immune Checkpoint Inhibition · principal investigator
- Ph1NCT03044613 · Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · active not recruiting · Gastric Cancer, Esophageal Cancer, GastroEsophageal Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 12 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Development and Evaluation of a Multilevel, Socio-Culturally Contextualized Digital Health Decision Intervention to Reduce Medical Mistrust and Improve Status-Neutral HIV Service Use among HLMSMU01PS005283 · NCHHSTP · JOHNS HOPKINS UNIVERSITY · fiscal years 2023 to 2026 · $500,000 awarded in 2026Same name and institution; not confirmed by an ID
- The Johns Hopkins Nursing Science Incubator for Systemic Solutions (N-SISS): Preparing Innovators to Address the Conditions of Daily Living and Redesign HealthR25NR021365 · NINR · JOHNS HOPKINS UNIVERSITY · fiscal years 2024 to 2026 · $258,296 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:59 UTC. The ranking covers the 200 most relevant of 28 PubMed records, and a shared surname and initials can bring in a namesake. All 28 on PubMed
- Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury.Ann Surg · 1983173 citationsRCR 9.4
- 122 citationsRCR 13.0
- Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity.Cancer Cell · 2022102 citationsRCR 5.8
- Milk supplementation of the diet of postmenopausal Chinese women on a low calcium intake retards bone loss.J Bone Miner Res · 200192 citationsRCR 2.9
- Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial.J Clin Oncol · 202289 citationsRCR 5.4
- First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1).J Immunother Cancer · 202368 citationsRCR 4.9
- Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer.J Immunother Cancer · 202249 citationsRCR 2.8
- Improving psychosocial outcomes for caregivers of people with poor prognosis gastrointestinal cancers: a randomized controlled trial (Family Connect).Support Care Cancer · 201635 citationsRCR 1.7
- 25 citationsRCR 1.4
- Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial.J Pain · 201124 citationsRCR 0.9